Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 812 participants.

Also called NCT01415505

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 812 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01415505
Other papers using this trial's data
  • Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study Journal of the American Society of Hypertension : JASH, 2014-12 DOI, PubMed 25492835

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01415505. Randomized; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
Condition
Hypertension
Intervention (Drug)
Nebivolol, Valsartan and Hydrochlorothiazide
Lead sponsor
Forest Laboratories (class: industry)

Record details

Record id
cardio:ct-nct01415505
Content hash
0c545a9b3eb3cc42bcbf64ecbc488f8e867798bd9c6ed1dc127a7ffd7fc8dc07